Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Tambaki, A."'
Autor:
Anna I. Kakafika, Stavroula Xenofontos, Vasilis Tsimihodimos, Afroditi P. Tambaki, Evangelia S. Lourida, Rigas Kalaitzidis, Marios A. Cariolou, Moses Elisaf, Alexandros D. Tselepis
Publikováno v:
Journal of Lipid Research, Vol 44, Iss 10, Pp 1919-1926 (2003)
The platelet-activating factor acetylhydrolase activity associated with high density lipoprotein (HDL-PAF-AH) may substantially contribute to the antioxidant, anti-inflammatory, and overall antiatherogenic effects of HDL. Two enzymes associated with
Externí odkaz:
https://doaj.org/article/e15aee48089642e689af5748800e3ac8
Autor:
Vasilis Tsimihodimos, Anna Kakafika, Afroditi P. Tambaki, Eleni Bairaktari, M.John Chapman, Moses Elisaf, Alexandros D. Tselepis
Publikováno v:
Journal of Lipid Research, Vol 44, Iss 5, Pp 927-934 (2003)
Human plasma platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme associated mainly with the apolipoprotein B (apoB)-containing lipoproteins and primarily with LDL. A small proportion of enzymatic activity is also associated with HDL. Pla
Externí odkaz:
https://doaj.org/article/47a145b2f23c4db89c2cb585e9cf0eb6
Autor:
Vasilis Tsimihodimos, Sonia-Athena P. Karabina, Afroditi P. Tambaki, Eleni Bairaktari, George Miltiadous, John A. Goudevenos, Marios A. Cariolou, M. John Chapman, Alexandros D. Tselepis, Moses Elisaf
Publikováno v:
Journal of Lipid Research, Vol 43, Iss 2, Pp 256-263 (2002)
Platelet-activating factor-acetylhydrolase (PAF-AH) is a lipoprotein-associated phospholipase A2 capable of hydrolyzing platelet-activating factor (PAF) and oxidatively modified phospholipids. We studied the plasma- and lipoprotein-associated PAF-AH
Externí odkaz:
https://doaj.org/article/365f59849a924c4584b92aa7345135e4
Autor:
G Karamanolis, Evgenia Koureta, Pantelis Karatzas, Garyfallia Kaltsa, M Tambaki, Eyfrosyni Laoudi, John Vlachogiannakos, T Voulgaris, Dimitrios Kamberoglou, Kostis Papaxoinis, George V. Papatheodoridis
Publikováno v:
ESGE Days 2021.
Autor:
Konstantinos Kintis, I. Iliakis, Alexandros Kasiakogias, Kyriakos Dimitriadis, Katerina Damianaki, M. Tambaki, K. Syrmali, Constantinos Tsioufis, Dimitrios Tousoulis, Dimitrios Petras, Dimitris Konstantinidis
Publikováno v:
European Heart Journal. 39
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases, Vol 10, Iss 1, Pp e2018049-e2018049 (2018)
Mediterranean Journal of Hematology and Infectious Diseases, Vol 10, Iss 1, Pp e2018049-e2018049 (2018)
Sickle cell disease patients often need regular blood transfusions to improve both the quality of life and survival from the veno-occlusive complications of the disease. Deferasirox, a convenient long acting oral agent, has recently been introduced i
Sickle cell disease patients often need regular blood transfusions to improve both the quality of life and survival from the veno-occlusive complications of the disease. Deferasirox, a convenient long acting oral agent, has recently been introduced i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::16708019fa970d22c87b705beefa45a1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107824
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107824
Autor:
E. Koutra, Kostas Tsioufis, T. Kalos, Dimitris Konstantinidis, Kyriakos Dimitriadis, I. Liatakis, Dimitrios Tousoulis, M. Tambaki
Publikováno v:
Journal of Hypertension. 36:e300-e301
Autor:
Mitsios, John V.1, Tambaki, Afroditi P.1, Abatzis, Morfis1, Biris, Nikolaos1, Sakarellos-Daitsiotis, Maria1, Sakanellos, Constantinos1, Soteriadou, Ketty2, Goudevenos, John3, Elisaf, Moses3, Tsoukatos, Demokritos1, Tsikaris, Vassilios1, Tselepis, Alexandros D.1 atselep@cc.uoi.gr
Publikováno v:
European Journal of Biochemistry. Feb2004, Vol. 271 Issue 4, p855-862. 8p.